• Financial Pearls for the Eye Care Professional 2022

  • Aug 23 2022
  • Duração: 24 minutos
  • Podcast

Financial Pearls for the Eye Care Professional 2022

  • Sumário

  • In this episode, Jose O. Segura, wealth management advisor and certified business exit planner, discusses establishing objectives within financial planning and organization, how to diversify your portfolio in ever-changing markets and more.

    • Intro :38
    • Welcome to another episode of Eye Care insider :52
    • About Jose Segura 1:03
    • For people that are listening for the first time, do you mind giving a brief of your background? 1:32
    • What are, in your opinion, some best practices in regard to financial planning? 2:58
    • Process for financial organization and seeking out advisors. 10:09
    • Can you talk about the importance of portfolio diversification? 12:07
    • Importance of maintaining your overall focus on financial planning and strategies when markets are effected. 16:56
    • Could you give us one pearl for our listeners, or one key economic update that you think would be really important to the current economic situation right now? 18:49
    • Thank you Jose 23:09
    • Any final words to our listeners? 23:11
    • Outro 23:35

     

    Jose O. Segura, is a wealth management advisor and certified business exit planner.

    We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN. For more information about Segura, visit www.joseosegura.com, reach him by email at jose_segura@wagllc.com, or call 518-867-3210 x104.

    Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; grant/research support from Alimera Sciences, Allergan/AbbVie, Chengdu Kanghong Biotechnology, Genentech, Notal Vision, Regeneron and Santen; consulting for Alimera Sciences, Allergan/AbbVie, Eyepoint Pharmaceuticals, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis, Regeneron and Sun Pharmaceuticals; speaker bureau for Alimera Sciences, Genentech, Kala Pharmaceuticals, Macular Degeneration Association, Notal Vision, Novartis and Sun Pharmaceuticals; and stock/shareholder with AbbVie and Regeneron. Segura reports he is a registered Representative and Financial Advisor of Park Avenue Securities LLC (PAS), 355 Lexington Avenue, 9 Fl., New York, NY 10017, 212-541-8800.

    Exibir mais Exibir menos

O que os ouvintes dizem sobre Financial Pearls for the Eye Care Professional 2022

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.